Source link : https://www.newshealth.biz/health-news/biosimilar-matches-aflibercept-for-diabetic-macular-edema/
TOPLINE: A biosimilar demonstrated comparable efficacy and safety to aflibercept in treating diabetic macular edema. The vascular endothelial growth factor (VEGF) inhibitor was one of two aflibercept biosimilars approved by the US Food and Drug Administration in May. METHODOLOGY: Researchers conducted a double-masked, randomized trial with 355 participants at 77 centers in the United States, […]
Author : News Health
Publish date : 2024-09-13 11:38:55
Copyright for syndicated content belongs to the linked Source.
Categories